| 상품명칭 |
nalfurafine |
| 별명 |
(2E)-N-[(5alpha,6beta)-17-(cyclopropylmethyl)-3,14-dihydroxy-4,5-epoxymorphinan-6-yl]-3-furan-3-yl-N-methylprop-2-enamide; (2E)-N-[(5alpha,6beta)-17-(cyclopropylmethyl)-3,14-dihydroxy-4,5-epoxymorphinan-6-yl]-3-(furan-3-yl)-N-methylprop-2-enamide; (E)-N-(17-(cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6beta-yl)-3-(furan-3-yl)-N-methylprop-2-enamide; 2-propenamide, N-[(5alpha,6beta)-17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-yl]-3-(3-furanyl)-N-methyl-, (2E)- |
| 분자식 |
C28H32N2O5 |
| 분자량 |
476.5641 |
| InChI |
InChI=1/C28H32N2O5/c1-29(23(32)7-4-18-9-13-34-16-18)20-8-10-28(33)22-14-19-5-6-21(31)25-24(19)27(28,26(20)35-25)11-12-30(22)15-17-2-3-17/h4-7,9,13,16-17,20,22,26,31,33H,2-3,8,10-12,14-15H2,1H3/b7-4+/t20-,22-,26+,27+,28-/m1/s1 |
| cas번호 |
152657-84-6 |
| 분자 구조 |
|
| 밀도 |
1.41g/cm3 |
| 비등점 |
700.7°C at 760 mmHg |
| 굴절 지수 |
1.696 |
| 인화점 |
377.6°C |
| 위험성 표시 |
|
| 리스크 규칙 |
|
| 보안 규칙 |
|
|
